MDxHealth SA
MDXH
$2.19
-$0.018-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 80.74M | 75.33M | 70.19M | 45.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 80.74M | 75.33M | 70.19M | 45.65M |
| Cost of Revenue | -- | 30.17M | 28.05M | 26.26M | 20.56M |
| Gross Profit | -- | 50.57M | 47.28M | 43.93M | 25.09M |
| SG&A Expenses | -- | 61.51M | 59.71M | 58.59M | 49.99M |
| Depreciation & Amortization | -- | 7.87M | 8.99M | 8.99M | 1.12M |
| Other Operating Expenses | -- | -254.00K | -272.00K | 461.00K | 802.00K |
| Total Operating Expenses | -- | 105.39M | 100.54M | 97.52M | 81.31M |
| Operating Income | -- | -24.65M | -25.21M | -27.33M | -35.66M |
| Income Before Tax | -- | -40.80M | -39.90M | -43.10M | -47.48M |
| Income Tax Expenses | -- | 1.00K | 1.00K | 1.00K | 0.00 |
| Earnings from Continuing Operations | -- | -40.80 | -39.90 | -43.10 | -47.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -40.80M | -39.90M | -43.10M | -47.48M |
| EBIT | -- | -24.65M | -25.21M | -27.33M | -35.66M |
| EBITDA | -- | -17.50M | -18.09M | -20.47M | -31.23M |
| EPS Basic | -- | -1.49 | -1.48 | -1.70 | -2.81 |
| Normalized Basic EPS | -- | -0.20 | -0.25 | -0.25 | -1.17 |
| EPS Diluted | -- | -1.49 | -1.48 | -1.70 | -2.81 |
| Normalized Diluted EPS | -- | -0.20 | -0.25 | -0.25 | -1.17 |
| Average Basic Shares Outstanding | -- | 109.54M | 107.76M | 102.40M | 69.01M |
| Average Diluted Shares Outstanding | -- | 109.54M | 107.76M | 102.40M | 69.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |